{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:15:45Z","timestamp":1788272145923,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-5380"],"award-info":[{"award-number":["IIRP-2023-5380"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108784","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T14:21:24Z","timestamp":1753021284000},"page":"108784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and biological evaluation of spirocyclopropyl oxindole-piperazine\/morpholine-based carboxamides as potential anticancer agents"],"prefix":"10.1016","volume":"163","author":[{"given":"Sowmya","family":"Dastari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samata","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanashree","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Reddyrajula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrilekha","family":"Chilvery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagula","family":"Shankaraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.108784_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer dependency map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108784_rf0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/cancers17040609","article-title":"Young adults and alcohol-associated liver Cancer: incidence and death from 2000 to 2021","volume":"17","author":"Danpanichkul","year":"2025","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108784_bb0015","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1021\/acs.jmedchem.1c00100","article-title":"Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy","volume":"64","author":"Shuai","year":"2021","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108784_bb0020","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jcb.30344","article-title":"Molecular mechanism of VEGF and its role in pathological angiogenesis","volume":"123","author":"Ahmad","year":"2022","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108784_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41420-022-00818-8","article-title":"Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors","volume":"8","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108784_bb0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Targete. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108784_bb0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jcb.25091","article-title":"The upregulation of PI3K\/Akt and MAP kinase pathways is associated with resistance of microtubule-targeting drugs in prostate cancer","volume":"116","author":"Liu","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108784_bb0040","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/cancers14071652","article-title":"PI3K\/AKT signaling tips the balance of cytoskeletal forces for cancer progression","volume":"14","author":"Deng","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108784_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","article-title":"2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF","volume":"3","author":"Mabjeesh","year":"2003","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108784_bb0050","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1517\/14728222.11.11.1443","article-title":"Tumour targeting by microtubule-depolymerising vascular disrupting agents","volume":"11","author":"Kanthou","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2025.108784_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107679","article-title":"Discovery of novel amide derivatives against VEGFR-2\/tubulin with potent antitumor and antiangiogenic activity","volume":"151","author":"Liu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104965","article-title":"Design and discovery of new antiproliferative 1, 2, 4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site","volume":"112","author":"Eissa","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejmech.2015.08.017","article-title":"Spirooxindole-derived morpholine-fused-1, 2, 3-triazoles: design, synthesis, cytotoxicity and apoptosis inducing studies","volume":"102","author":"Senwar","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113263","article-title":"Anticancer potential of spirocompounds in medicinal chemistry: a pentennial expedition","volume":"215","author":"Bora","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-016-2932-6","article-title":"A novel spiroindoline targets cell cycle and migration via modulation of microtubule cytoskeleton","volume":"429","author":"Kumar","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108784_bb0080","doi-asserted-by":"crossref","first-page":"202400052","DOI":"10.1002\/cmdc.202400052","article-title":"Development of Benzimidazole-substituted Spirocyclopropyl Oxindole derivatives as cytotoxic agents: tubulin polymerization inhibition and apoptosis inducing studies","volume":"19","author":"Sakla","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108784_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-017-0301-5","article-title":"Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene) methylpyrrole derivatives as potential VEGFR-2\/PDGFR\u03b2 inhibitors","volume":"11","author":"Yang","year":"2017","journal-title":"Chem. Cent. J."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108784_bb0090","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1080\/07391102.2022.2127907","article-title":"In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl) naphthalene-2-ol derivative","volume":"41","author":"Elkaeed","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108784_bb0095","article-title":"Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers","volume":"107","author":"Eissa","year":"2023","journal-title":"Comput. Boil. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0100","doi-asserted-by":"crossref","unstructured":"Srinivas, B., Dasari, G., Syeda, A.B., Palabindela, R. and Srinivas, B., Design and synthesis of quinoxaline-piperazine-pyrazolo conjugates as VEGFR-2 targeting agents and ADMET studies. Results Chem., 102331.","DOI":"10.1016\/j.rechem.2025.102331"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108784_rf0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/pharmaceutics11010023","article-title":"Effects of piperazine derivative on paclitaxel pharmacokinetics","volume":"11","author":"Lee","year":"2019","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108784_rf0110","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/ph17101320","article-title":"Arylpiperazine derivatives and Cancer: a new challenge in medicinal chemistry","volume":"17","author":"Andreozzi","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108784_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11030-023-10603-z","article-title":"New antiproliferative 3-substituted oxindoles inhibiting EGFR\/VEGFR-2 and tubulin polymerization","volume":"28","author":"Ezelarab","year":"2024","journal-title":"Mol. Divers."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108784_bb0115","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1021\/jo035060c","article-title":"Diastereoselective synthesis of cyclopropane amino acids using diazo compounds generated in situ","volume":"68","author":"Adams","year":"2003","journal-title":"J. Organomet. Chem."},{"issue":"72","key":"10.1016\/j.bioorg.2025.108784_bb0120","doi-asserted-by":"crossref","first-page":"38425","DOI":"10.1039\/C4RA05755D","article-title":"Diastereoselective synthesis of spiro [cyclopropane-1, 3\u2032-indolin]-2\u2032-ones through metal-free cyclopropanation using tosylhydrazone salts","volume":"4","author":"Kapure","year":"2014","journal-title":"RSC Adv."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108784_rf0130","doi-asserted-by":"crossref","first-page":"16623","DOI":"10.1039\/D5RA01632K","article-title":"New spirooxindole pyrrolidine\/pyrrolizidine analogs: design, synthesis, and evaluation as an anticancer agent","volume":"15","author":"Nivetha","year":"2025","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108784_rf0135","first-page":"1778","article-title":"Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cells. RSC","volume":"14","author":"Girst","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_or0010","doi-asserted-by":"crossref","unstructured":"Al-Rashood, S.T., Hamed, A.R., Hassan, G.S., Alkahtani, H.M., Almehizia, A.A., Alharbi, A., Al-Sanea, M.M. and Eldehna, W.M., Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity. J. Enzyme Inhib. Med. Chem., (2020), 35(1), 831-839.","DOI":"10.1080\/14756366.2020.1743281"},{"key":"10.1016\/j.bioorg.2025.108784_rf0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106124","article-title":"Novel spirooxindole based benzimidazole scaffold: In vitro, nanoformulation and in vivo studies on anticancer and antimetastatic activity of breast adenocarcinoma","volume":"129","author":"Barakat","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0130","article-title":"Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines","volume":"21(8),1013","author":"Pe\u00f1a-Mor\u00e1n","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108784_bb0135","doi-asserted-by":"crossref","first-page":"134078","DOI":"10.1016\/j.molstruc.2022.134078","article-title":"Benzimidazole based bis-carboxamide derivatives as promising cytotoxic agents: Design, synthesis, in silico and tubulin polymerization inhibition","volume":"1271","author":"Laxmikeshav","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108784_bb0140","series-title":"Advanced Protocols in Oxidative Stress II","first-page":"57","article-title":"Identification of ROS using oxidized DCFDA and flow-cytometry","author":"Eruslanov","year":"2010"},{"key":"10.1016\/j.bioorg.2025.108784_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12659\/MSMBR.893327","article-title":"Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry","volume":"21","author":"Liu","year":"2015","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108784_bb0150","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-protoc."},{"key":"10.1016\/j.bioorg.2025.108784_bb0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1387-2656(05)11013-8","article-title":"Cell migration\/invasion assays and their application in cancer drug discovery","volume":"11","author":"Eccles","year":"2005","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.bioorg.2025.108784_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-015-0529-y","article-title":"CFAssay: statistical analysis of the colony formation assay","volume":"10","author":"Braselmann","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.bioorg.2025.108784_rf0185","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10895-018-2306-4","article-title":"The detailed comparison of cell death detected by annexin V-PI counterstain using fluorescence microscope, flow cytometry and automated cell counter in mammalian and microalgae cells","volume":"28","author":"Ko\u00e7","year":"2018","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.bioorg.2025.108784_rf0190","doi-asserted-by":"crossref","first-page":"103317","DOI":"10.1016\/j.bioorg.2019.103317","article-title":"Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors","volume":"93","author":"Sana","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108784_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0248-4900(93)90110-Z","article-title":"Cell cycle analysis by flow cytometry: principles and applications","volume":"78","author":"Jayat","year":"1993","journal-title":"Biol. Cell."},{"key":"10.1016\/j.bioorg.2025.108784_rf0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2012.08.021","article-title":"Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents","volume":"56","author":"Kamal","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_rf0205","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.bmc.2017.07.031","article-title":"Synthesis of different heterocycles-linked chalcone conjugates as cytotoxic agents and tubulin polymerization inhibitors","volume":"25","author":"Shankaraiah","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108784_bb0180","doi-asserted-by":"crossref","first-page":"202400422","DOI":"10.1002\/cmdc.202400422","article-title":"Design, development of Pyrazole-linked Spirocyclopropyl Oxindole-Carboxamides as potential cytotoxic agents and type III allosteric VEGFR-2 inhibitors","volume":"19","author":"Valapil","year":"2024","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108784_bb0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/bit.27227","article-title":"A dynamic culture platform enhances the efficiency of the 3D HUVEC-based tube formation assay","volume":"117","author":"Lovecchio","year":"2020","journal-title":"Biotechnol. Bioeng."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108784_bb0190","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/molecules30050987","article-title":"Anti-Angiogenic potential of marine Streptomyces-derived Lucknolide a on VEGF\/VEGFR2 signaling in human endothelial cells","volume":"30","author":"Choi","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108784_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112457","article-title":"Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect","volume":"200","author":"Sana","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108784_bb0200","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2174\/1568026614666141130092853","article-title":"QSAR and 3D-QSAR models in the field of tubulin inhibitors as anticancer agents","volume":"14","author":"Marzaro","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108784_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135890","article-title":"Exploration of 1, 3, 5-trisubstituted pyrazoline derivatives as human carbonic anhydrase inhibitors: synthesis, biological evaluation and in silico studies","volume":"280","author":"Srikanth","year":"2024","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:53:13Z","timestamp":1776919993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0045206825006649"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108784","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of spirocyclopropyl oxindole-piperazine\/morpholine-based carboxamides as potential anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108784"}}